Skip to main content

Journals in Allergy and clinical immunology

Allergology International

  • ISSN: 1323-8930
  • 5 Year impact factor: 6.6
  • Impact factor: 6.2
Allergology International is the official journal of the Japanese Society of Allergology and publishes original papers dealing with the etiology, diagnosis and treatment of allergic and related diseases. Papers may include the study of methods of controlling allergic reactions, human and animal models of hypersensitivity and other aspects of basic and applied clinical allergy in its broadest sense.The Journal aims to encourage the international exchange of results and encourages authors from all countries to submit papers in the following three categories: Original Articles, Review Articles, and Letters to the Editor.The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are peer reviewed by two anonymous reviewers and the Editor.

Allergy Medicine

  • ISSN: 2949-9135
A significant and growing portion of the general population suffers from various types of allergies, leading to distress and a reduced quality of life for affected individuals, as well as substantial costs for society. It is important to note that allergies often coexist with other medical conditions. Common comorbidities in allergy patients include anxiety, depression, gastroesophageal reflux disease (GERD), and obesity, particularly in those with difficult-to-treat or severe asthma. It is recommended to actively manage these comorbidities in allergy patients, as they can contribute to symptom burden, impair quality of life, and result in medication interactions. Additionally, certain comorbidities can negatively impact asthma control. Moreover, there is a growing concern regarding allergy-related comorbidities, as evidenced by the increasing number of relevant articles published each year. However, there is a lack of professional journals dedicated to allergy-related comorbidities for effective professional communication. Allergy Medicine, the official journal of the Chinese Research Hospital Association (CRHA), aims to fill this gap by publishing new research, reviews, and case studies in basic, clinical, and translational medicine, focusing on allergic science and the field of allergy comorbidity and multimorbidity. The journal emphasizes the mechanisms, preventive measures, and treatment strategies associated with these conditions, providing a professional platform for a comprehensive, up-to-date, and in-depth understanding of allergy medicine.

Annals of Allergy, Asthma & Immunology

  • ISSN: 1081-1206
  • 5 Year impact factor: 5.6
  • Impact factor: 5.8
Official Journal of the American College of Allergy, Asthma & ImmunologyAnnals of Allergy, Asthma & Immunology is a scholarly medical journal published monthly by the American College of Allergy, Asthma & Immunology. The purpose of Annals is to serve as an objective evidence-based forum for the allergy/immunology specialist to keep up to date on current clinical science (both research and practice-based) in the fields of allergy, asthma, and immunology. The emphasis of the journal will be to provide clinical and research information that is readily applicable to both the clinician and the researcher. Each issue of the Annals shall also provide opportunities to participate in accredited continuing medical education activities to enhance overall clinical proficiency.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Annals of Anatomy

  • ISSN: 0940-9602
  • 5 Year impact factor: 2.2
  • Impact factor: 2
Anatomischer AnzeigerAnnals of Anatomy publish peer reviewed original articles as well as brief review articles. The journal is open to original papers covering a link between anatomy and areas such as• molecular biology, • cell biology • reproductive biology • immunobiology • developmental biology, neurobiology • embryology as well as • neuroanatomy • neuroimmunology • clinical anatomy • comparative anatomy • modern imaging techniques • evolution, and especially also • agingMoreover, manuscripts dealing with all forms of anatomical teaching and new forms of curricula will be considered for publication. Priority will be given to experimental studies; merely descriptive studies will only be published if the Editors consider that they are of functional significance.For more than a century the Annals of Anatomy have been one of the most famous and widespread journals on morphology. The journal is the official journal of the Anatomische Gesellschaft (Anatomical Society).

Cell Reports Medicine

  • ISSN: 2666-3791
  • Impact factor: 11.7
Cell Reports Medicine is a premium open-access journal from Cell Press publishing cutting-edge research in translational and clinical biomedical sciences that inform and influence human health and medicine.The content published in Cell Reports Medicine reaches a broad range of scientists and clinicians across the spectrum of medical disciplines, ensuring that your work will be both visible and accessible. The journal publishes original research that ranges from exciting concepts in human biology, health, and disease to all phases of clinical work. We encourage submissions featuring innovative ideas that open up new directions in clinical research and practice, as well as studies that provide critical information that enriches our understanding of current standards of care in diagnosis, treatment, and prognosis. This includes, but is not limited to, translational studies, clinical trials in all areas of medicine including long-term trial follow-ups as well as work in genomics, biomarker discovery, and developments in technology that contribute to diagnostics, treatment, and healthcare. Studies based on vertebrate model organisms also fall within the scope of the journal, provided that the results are directly relevant to human health and disease.Like our sister journal Cell Reports, we will consider impactful, single-point papers called reports, in addition to longer articles. Large datasets, techniques, and tools for the community can also be considered under the article format. We will also publish reviews covering recent literature in emerging and active fields.The professional in-house scientific editors at Cell Reports Medicine work closely with authors, reviewers, and the journal's editorial board to ensure exemplary editorial process, fair and robust peer review, and rapid dissemination and communication of your research.Visit the Cell Press website for more information about Cell Reports Medicine - http://www.cell.com/cell-reports-medicine/home

Heliyon

  • ISSN: 2405-8440
  • 5 Year impact factor: 3.9
  • Impact factor: 3.4
Heliyon considers research from all areas of the physical, applied, life, social and medical sciences. We publish manuscripts reporting scientifically accurate and valuable research, which adheres to accepted ethical and scientific publishing standards. As such Heliyon publishes new insights as well as extensions on existing theories, negative/null results and replication studies.Submissions covering arts, humanities and law are not considered in Heliyon. Authors of these submissions are encouraged to submit directly to our partner journal Social Sciences & Humanities Open.Heliyon classifies manuscripts/articles into different sections based on the research topic discussed. Some sections exclude certain types of studies from their scope. To know more and to see the kind of manuscripts the various sections publish, please visit: https://www.cell.com/heliyon/sectionsA dedicated in-house editorial office team, internal editors as well as external academic section and associate editors handle your manuscript and manage the publication process, giving your research the editorial support and quality control it deserves.If it's important to you, it's important to us. Submit your paper today.

Immunobiology

  • ISSN: 0171-2985
  • 5 Year impact factor: 2.7
  • Impact factor: 2.5
Immunobiology is a broad-scope and inclusive Gold Open Access journal dedicated to publishing innovative research across a wide range of immunological subjects. Immunobiology aims to foster a comprehensive understanding of immunology by bridging the gap between scientists and clinicians.The journal publishes topics including:Innate and Adaptive Immunity Molecular Mechanisms, Including Normal and Pathological Functions of the Immune Response, Immune Cell Biology, Cytokines, and Soluble Mediators. Complement Biology, Pathology, and Therapeutics. Microbial Immunology and Immunopathology of Infectious Diseases (Bacterial, Viral and Parasitic) Cancer Immunology Neuroimmunology Immunogenetics Immunopathology of allergic and autoimmune diseases Vaccines and Immunotherapeutics Clinical Immunology Immunobiology does not accept submissions consisting mainly of (a) bioinformatics or computational analysis of public genomic or transcriptomic databases and (b) testing and evaluation of previously uncharacterized natural product-based drug candidates. Immunobiology does not accept reviews that are not by invitation.Founded in 1909 as the first-ever specialist immunology journal, Immunobiology has a rich history of contributing to the field. It aims to become the most inclusive journal for the dissemination of rigorous immunological research, supporting the global scientific community in advancing the field.

Immunology and Allergy Clinics of North America

  • ISSN: 0889-8561
  • 5 Year impact factor: 3.1
  • Impact factor: 2.7
Immunology and Allergy Clinics of North America updates you on the latest trends in patient management; keeps you up to date on the newest advances; and provides a sound basis for choosing treatment options. Each issue focuses on a single topic in immunology and allergy and is presented under the direction of an experienced guest editor. Topics include allergens, immunotherapy, anaphylaxis, asthma, drug allergy, eosinophilrelated disorders, food allergy, immunodeficiency states (non-HIV), basic science, mast cell disorders, rhinitis and sinusitis, and urticaria and angioedema. Immunology and Allergy Clinics of North America is published four times each year, in February, May, August, and November.

Journal of Allergy and Clinical Immunology

  • ISSN: 0091-6749
  • 5 Year impact factor: 10.2
  • Impact factor: 11.4
Official Journal of the American Academy of Allergy, Asthma and ImmunologyThe Journal of Allergy and Clinical Immunology publishes high-impact, cutting-edge basic, clinical and translational research papers in Allergy, Asthma and Immunology. Articles cover such topics as asthma, food allergy, allergic rhinitis, atopic dermatitis, primary immune deficiencies, occupational and environmental allergy, and other allergic and immunologic diseases, and include clinical trials and mechanistic studies that report on novel therapies, insights into underlying mechanisms, and other discoveries that will inform our understanding of these diseases and ultimately improve the diagnosis and management of patients. With an impact factor of 14.2, the journal ranks 1st of 38 in the Allergy category and 11th of 177 in the Immunology category in the 2022 Journal Citation Reports®, published by Clarivate.Authors are also welcome to submit to the journal's companion titles, The Journal of Allergy and Clinical Immunology: In Practice and the Gold Open Access title, The Journal of Allergy and Clinical Immunology: Global. For more information on the articles reviewed by JACI: In Practice and JACI: Global, please visit their respective websites which are linked here: www.jaci-inpractice.org www.jaci-global.org

Journal of Allergy and Clinical Immunology: Global

  • ISSN: 2772-8293
JACI: Global is a peer-reviewed, open access, online publication of the American Academy of Allergy, Asthma & Immunology (AAAAI), which started publishing in 2021. It joins the other members of the AAAAI family of journals - The Journal of Allergy and Clinical Immunology (JACI) and JACI: In Practice, respectively two of the most highly-cited allergy and clinical immunology journals (2023 Journal Citation Reports, published by Clarivate Analytics).Mission The overall mission of JACI: Global is to provide authors with a fully Open Access journal for allergy/immunology-relevant work that includes global and regional perspectives, with no barrier to access for anyone with an internet connection.Scope As the AAAAI's Open Access journal, JACI: Global publishes reports describing original research - basic, translational and clinical - related to all aspects of allergy, immunology, and related fields. This very broad scope mirrors the scope of its two companion journals. In addition to translational content, JACI: Global publishes basic science, Phase I/II clinical trials, population studies, as well as regionally relevant research relating to allergy and immunology.JACI: Global provides a (high-)quality outlet for authors whose funders require them to publish in a Gold Open Access journal. One of the journal's hallmarks is its geographic diversity, with an emphasis on global and regional research and practice. This makes the journal particularly appealing to authors working in Research4Life countries, with waivers or deep discounts of accepted Article Processing Charges (APCs) automatically provided by our publisher, Elsevier. JACI: Global also provides an important service to the growing number of funders who have joined Plan S (the European cOAlition S initiative) that requires full Open Access of research funded by its members, including the Gates Foundation, the Wellcome Trust, UK Research and Innovation, and the World Health Organization (see https://www.coalition-s.org).For all articles submitted before 31 December 2024 there is a 50% discount on the APC.Content All JACI: Global content is peer-reviewed. Content flows to JACI: Global from three primary sources:Authors may submit directly to JACI: Global.The Editors-in-Chief of JACI and JACI: In Practice may recommend that authors, whose papers are not suitable for acceptance in these journals, to consider submitting to JACI: Global which has a broader scope and includes developmental and early stage research, as well as informative case reports. This provides a valued service to authors which may expedite publication of their research.The Editors of JACI: Global may invite submissions of articles.In order to facilitate the transfer of papers which are of sound science but not accepted by JACI or JACI: In Practice, JACI: Global uses the same article types as JACI.Notice Practitioners and researchers must always rely on their own experience and knowledge in evaluating and using any information, methods, compounds or experiments described herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. To the fullest extent of the law, no responsibility is assumed by the publisher or the American Academy of Allergy, Asthma & Immunology for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein.   Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.